Land: Singapore
Taal: Engels
Bron: HSA (Health Sciences Authority)
SIEMENS HEALTHCARE PTE. LTD.
Class C IVD
Siemens Healthcare Diagnostics Inc
Immunology
It is for in vitro diagnostic use in the quantitative determination of B-type Natriuretic Peptide (BNP) in human plasma using the ADVIA Centaur and ADVIA Centaur XP systems. This assay is indicated for the measurement of plasma BNP as an aid in the diagnosis and assessment of the severity of heart failure. In patients with acute coronary syndromes (ACS), this test, in conjunction with other known risk factors, can also be used to predict survival as well as to predict the likelihood of future heart failure. This assay is not intended for use on any other system.
Models: ADVIA Centaur XP Immunoassay System Analyzer - 078-A010-07, ADVIA Centaur Immunoassay System Analyzer - 078-A001-14, ADVIA Centaur BNP Reagent - 02816138, ADVIA Centaur BNP Reagent - 02816634, ADVIA Centaur BNP 1, 2, 3 Quality Control Material - 02817045, ADVIA Centaur BNP Calibrator - 02817266, Kit, SW V5.2.3.1 Service Pack 1 - 10814360, Kit, SW V7.1.1.2, International - 10814106, Kit, SW V4.0.4.4 Service Pack 4 - 10814401, ADVIA Centaur Wash 1 - 01137199 (112351), ADVIA Centaur Wash 1 - 03773025, ADVIA Centaur Multi-Diluent 1 - 07907174 (110313), ADVIA Centaur Multi-Diluent 1 - 07293184 (110312), Multi-Diluent 1 - 09348792 (672177), BNP Master Curve Material - 02815905, ADVIA Centaur Multi-Diluent 15 - 11200097, ADVIA Centaur® XP Immunoassay System - 078-A011-R03
2011-03-01